Scientific work

Prof. Dr. Nurhan Ergül

86 publications. The source of the information is stated next to each publication.

Back to profile

  1. Clinical Value of 68 Ga-DOTA-Bombesin PET/CT Compared With 18 F-FDG PET/CT in the Staging of Breast Cancer

    Clinical nuclear medicine, 2026

    DOI 10.1097/rlu.0000000000006582 PMID 42305081 Open-access full textSource: Europe PMC

  2. Comparative Performance of 68Ga-FAPI-04 and 18F-FDG PET/CT in Ovarian Cancer: Focus on Peritoneal Carcinomatosis

    World Journal of Nuclear Medicine, 2026

    DOI 10.1055/s-0046-1819631 PMID 42077575 Open-access full textSource: OpenAlex

  3. Can PSMA-Targeting Radiopharmaceuticals Be Useful for Detecting Brain Metastasis of Various Tumors Using Positron Emission Tomography?

    Cancers, 2025

    DOI 10.3390/cancers17183088 PMID 41008930 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  4. 18F-FDG PET/CT and 68Ga-DOTATATE PET/CT Findings of Polycystic Kidney-derived Paraganglioma

    Molecular imaging and radionuclide therapy, 2024

    DOI 10.4274/mirt.galenos.2024.03264 PMID 39373189 Open-access full textSource: Europe PMC

  5. Does Radioactive Iodine Treatment Damage the Lacrimal System?

    Clinical nuclear medicine, 2024

    DOI 10.1097/rlu.0000000000005147 PMID 38451916 Source: ORCID

  6. Contribution of 68Ga-DOTA-FAPI-04 PET/CT to Prostate Cancer Imaging

    Clinical Nuclear Medicine, 2024

    DOI 10.1097/rlu.0000000000005064 PMID 38271254 18 citations (OpenAlex) Source: OpenAlex

  7. The Contribution of 68Ga-FAPI-04 PET/CT to Staging and Prognosis in Gastric Cancer

    Clinical Nuclear Medicine, 2024

    DOI 10.1097/rlu.0000000000005394 PMID 39086038 18 citations (OpenAlex) Source: OpenAlex

  8. Dual 177Lu–Prostate-Specific Membrane Antigen and 177Lu-DOTATATE Therapy in Metastatic Castration-Resistant Prostate Cancer With Neuroendocrine Differentiation

    Clinical Nuclear Medicine, 2024

    DOI 10.1097/rlu.0000000000005131 PMID 38409763 4 citations (OpenAlex) Source: OpenAlex

  9. 68Ga-DOTA-FAPI-46 PET/CT Imaging for Restaging in a Patient With Metastatic Pheochromocytoma

    Clinical Nuclear Medicine, 2024

    DOI 10.1097/rlu.0000000000005481 PMID 39365092 3 citations (OpenAlex) Source: OpenAlex

  10. Physiological Gallbladder Accumulation on 68Ga-FAPI-46 PET/CT

    Clinical Nuclear Medicine, 2024

    DOI 10.1097/rlu.0000000000005480 PMID 39466623 2 citations (OpenAlex) Source: OpenAlex

  11. Radiation Therapy–Induced Fibrous Histiocytoma, Mimicking Local Recurrence and Detected by 18F-FDG PET/CT in a Patient With Breast Cancer

    Clinical Nuclear Medicine, 2024

    DOI 10.1097/rlu.0000000000005320 PMID 38914095 1 citation (OpenAlex) Source: OpenAlex

  12. Molecular Imaging in Colorectal Cancer

    Nuclear Medicine Seminars, 2024

    DOI 10.4274/nts.galenos.2024.0017 Open-access full textSource: OpenAlex

  13. 18F-FDG PET/CT Imaging Findings in Adult-Onset Rasmussen Encephalitis

    Clinical Nuclear Medicine, 2024

    DOI 10.1097/rlu.0000000000005437 PMID 39325505 Source: OpenAlex

  14. Primary Squamous Cell Carcinoma of the Breast With 18F-FDG PET/CT

    Clinical Nuclear Medicine, 2024

    DOI 10.1097/rlu.0000000000005506 PMID 39385373 Source: OpenAlex

  15. 68Ga-FAPI-04 PET/CT in Selected Breast Cancer Patients With Low FDG Affinity A Head-to-Head Comparative Study

    Clinical Nuclear Medicine, 2023

    DOI 10.1097/rlu.0000000000004751 PMID 37351868 32 citations (Europe PMC) Source: ORCID

  16. The roles of 68Ga-PSMA PET/CT and 18F-FDG PET/CT imaging in patients with triple-negative breast cancer and the association of tissue PSMA and claudin 1, 4, and 7 levels with PET findings

    Nuclear Medicine Communications, 2023

    DOI 10.1097/mnm.0000000000001663 PMID 36756767 10 citations (Europe PMC) Source: ORCID

  17. Pneumonia with Intense 68Ga-FAPI Uptake Mimicking Metastasis on 68Ga-FAPI PET/CT in a Patient with Rectal Cancer

    Molecular imaging and radionuclide therapy, 2023

    DOI 10.4274/mirt.galenos.2023.07830 PMID 37870301 4 citations (Europe PMC) Open-access full textSource: Europe PMC

  18. Testicular Metastasis of Jejunal Neuroendocrine Tumor on 68Ga-DOTATATE PET/CT

    Molecular imaging and radionuclide therapy, 2023

    DOI 10.4274/mirt.galenos.2022.06926 PMID 37337848 2 citations (Europe PMC) Open-access full textSource: Europe PMC

  19. 68Ga-FAPI-04 PET/CT Findings in Patients with Liver Cirrhosis

    Molecular imaging and radionuclide therapy, 2023

    DOI 10.4274/mirt.galenos.2022.80774 PMID 37337827 9 citations (Europe PMC) Open-access full textSource: Europe PMC

  20. Cutaneous Metastase of Rectal Neuroendocrine Carcinoma Revealed on 18F-FDG PET/CT

    Molecular imaging and radionuclide therapy, 2023

    DOI 10.4274/mirt.galenos.2022.99266 PMID 37337847 Open-access full textSource: Europe PMC

  21. 68Ga-PSMA and 68Ga-FAPI-04 PET/CT Findings With 18F-FDG PET/CT in a Patient With Recurrent Prostate Cancer

    Clinical Nuclear Medicine, 2023

    DOI 10.1097/rlu.0000000000004522 PMID 36723899 9 citations (OpenAlex) Source: OpenAlex

  22. The potential role of 68Ga-FAPI-04 PET/CT for screening malignancy in suspected colonic lesions

    Nuclear Medicine Communications, 2023

    DOI 10.1097/mnm.0000000000001734 PMID 37450605 8 citations (OpenAlex) Source: OpenAlex

  23. A Comparison of 18F-FDG PET/CT and 68Ga-PSMA PET/CT in Detecting Osteonecrosis of the Jaw in a Patient With Prostate Cancer

    Clinical Nuclear Medicine, 2023

    DOI 10.1097/rlu.0000000000004970 PMID 38170920 7 citations (OpenAlex) Source: OpenAlex

  24. 68Ga-FAPI-04 PET/CT In Primary Signet Ring–Like Cell Carcinoma of Prostate With Bone Metastases

    Clinical Nuclear Medicine, 2023

    DOI 10.1097/rlu.0000000000004550 PMID 36728151 7 citations (OpenAlex) Source: OpenAlex

  25. Effect of Leflunomide Use on 68Ga-DOTATATE Biodistribution in a Case With Neuroendocrine Tumor

    Clinical Nuclear Medicine, 2023

    DOI 10.1097/rlu.0000000000004517 PMID 36607376 3 citations (OpenAlex) Source: OpenAlex

  26. 68Ga-DOTA-FAPI-04 Imaging of Bilateral Phyllodes Tumor

    Clinical Nuclear Medicine, 2023

    DOI 10.1097/rlu.0000000000004782 PMID 37565817 3 citations (OpenAlex) Source: OpenAlex

  27. 99mTc-PSMA targeted robot-assisted radioguided surgery during radical prostatectomy and extended lymph node dissection of prostate cancer patients

    Annals of Nuclear Medicine, 2022

    DOI 10.1007/s12149-022-01741-9 PMID 35426599 18 citations (Europe PMC) Source: OpenAlex

  28. Mild 68Ga PSMA-11 Uptake in Incidental Pituitary Adenoma

    Molecular imaging and radionuclide therapy, 2022

    DOI 10.4274/mirt.galenos.2021.97752 PMID 36268938 4 citations (Europe PMC) Open-access full textSource: Europe PMC

  29. Multiple Subcutaneous 18F-FDG-avid Granulomas Due to Enoxaparin Injection

    Molecular imaging and radionuclide therapy, 2022

    DOI 10.4274/mirt.galenos.2021.87487 PMID 35771074 Open-access full textSource: Europe PMC

  30. Two Cases of Acrometastasis from Lung Cancer Revealed on 18F-FDG PET/CT

    Molecular imaging and radionuclide therapy, 2022

    DOI 10.4274/mirt.galenos.2021.16013 PMID 35771075 1 citation (Europe PMC) Open-access full textSource: Europe PMC

  31. Prognostic Significance of 18F-FDG PET/CT Imaging in Survival Outcomes in Patients with Renal Cell Carcinoma

    Molecular imaging and radionuclide therapy, 2022

    DOI 10.4274/mirt.galenos.2022.42744 PMID 36268871 1 citation (Europe PMC) Open-access full textSource: Europe PMC

  32. The value of 99mTc-MIBI scan in the detection of malignancy potential of hypermetabolic thyroid incidentalomas of 18F-FDG PET/CT

    Médecine Nucléaire, 2022

    DOI 10.1016/j.mednuc.2022.01.131 1 citation (OpenAlex) Source: OpenAlex

  33. Complex Fibroadenoma Mimicking Breast Cancer on 68Ga-FAPI-04 and 18F-FDG PET/CT

    Clinical Nuclear Medicine, 2022

    DOI 10.1097/rlu.0000000000004495 PMID 36723896 9 citations (OpenAlex) Source: OpenAlex

  34. 18F-FDG PET/CT in Urethral Metastases From Bladder Cancer

    Clinical Nuclear Medicine, 2022

    DOI 10.1097/rlu.0000000000004358 PMID 35961619 5 citations (OpenAlex) Source: OpenAlex

  35. Chronic Gastritis Mimicking Malignancy on 68Ga-FAPI-04 PET/CT

    Clinical Nuclear Medicine, 2022

    DOI 10.1097/rlu.0000000000004439 PMID 36240789 5 citations (OpenAlex) Source: OpenAlex

  36. 18F-FDG PET/CT and 68Ga-DOTATATE PET/CT Findings in a Patient With Primary Renal Well-Differentiated Neuroendocrine Tumor

    Clinical Nuclear Medicine, 2022

    DOI 10.1097/rlu.0000000000004198 PMID 35384913 4 citations (OpenAlex) Source: OpenAlex

  37. Role of 68Ga-FAPI PET/CT in Screening Malignancy of Familial Adenomatous Polyposis

    Clinical Nuclear Medicine, 2022

    DOI 10.1097/rlu.0000000000004432 PMID 36240760 3 citations (OpenAlex) Source: OpenAlex

  38. Contribución de las imágenes PET/TC con 18F-FDG en el diagnóstico y manejo de pacientes VIH positivos

    Revista Española de Medicina Nuclear e Imagen Molecular, 2022

    DOI 10.1016/j.remn.2021.10.001 Source: OpenAlex

  39. 68Ga-PSMA PET/CT Versus 18F-FDG PET/CT for Imaging of Hepatocellular Carcinoma

    Molecular imaging and radionuclide therapy, 2021

    DOI 10.4274/mirt.galenos.2021.92053 PMID 34082503 21 citations (Europe PMC) Open-access full textSource: Europe PMC

  40. 18F-FDG PET/CT and 68Ga-FAPI-4 PET/CT Findings of Bilateral Knee Osteoarthritis in a Patient With Uveal Malignant Melanoma

    Clinical Nuclear Medicine, 2021

    DOI 10.1097/rlu.0000000000003854 PMID 34319962 29 citations (OpenAlex) Source: OpenAlex

  41. Contribution of 18F-FDG PET/CT imaging in the diagnosis and management of HIV-positive patients

    Revista Española de Medicina Nuclear e Imagen Molecular (English Edition), 2021

    DOI 10.1016/j.remnie.2021.10.005 PMID 34794914 7 citations (OpenAlex) Source: OpenAlex

  42. Synchronous Bilateral Adrenal Gland Metastases of Bladder Carcinoma Revealed on 18F-FDG PET/CT

    Clinical Nuclear Medicine, 2021

    DOI 10.1097/rlu.0000000000003666 PMID 33883483 2 citations (OpenAlex) Source: OpenAlex

  43. Prognostic Role of Interleukin-23 in Prostate Adenocarcinoma: Comparison with Gallium-68 Prostate-Specific Membrane Antigen-11 Positron Emission Tomography/Computed Tomography Findings

    Istanbul Medical Journal, 2021

    DOI 10.4274/imj.galenos.2021.70487 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  44. Recurrent Brain Metastasis of Triple Negative Breast Cancer With High Uptake in 68Ga-PSMA-11 PET/CT

    Clinical Nuclear Medicine, 2020

    DOI 10.1097/rlu.0000000000003336 PMID 33065618 15 citations (OpenAlex) Source: OpenAlex

  45. Solitary Vulvar Involvement of Ovarian Non-Hodgkin Lymphoma Mimicking Bartholin’s Abscess on 18F-FDG PET/CT

    Clinical Nuclear Medicine, 2020

    DOI 10.1097/rlu.0000000000003494 PMID 33351504 3 citations (OpenAlex) Source: OpenAlex

  46. Comparison of preoperative locoregional Ga‐68 PSMA‐11 PET‐CT and mp‐MRI results with postoperative histopathology of prostate cancer

    The Prostate, 2019

    DOI 10.1002/pros.23812 PMID 31012125 42 citations (Europe PMC) Source: OpenAlex

  47. Effect of External Cooling on 177Lu-PSMA Uptake by the Parotid Glands

    Journal of Nuclear Medicine, 2019

    DOI 10.2967/jnumed.119.226449 PMID 30850503 49 citations (OpenAlex) Open-access full textSource: OpenAlex

  48. The ability of pre-treatment F-18 FDG PET/CT metabolic parameters for predicting axillary lymph node and distant metastasis and overall survival

    Nuclear Medicine Communications, 2019

    DOI 10.1097/mnm.0000000000001085 PMID 31469807 7 citations (OpenAlex) Source: OpenAlex

  49. The Evaluation of External Dose Rate Measurements of Patients During and After F-18 FDG PET/CT Imaging and Appropriate Discharge Time from PET/CT Department

    Istanbul Medical Journal, 2019

    DOI 10.4274/imj.85698 4 citations (OpenAlex) Open-access full textSource: OpenAlex

  50. 68Ga-PSMA-11 PET/CT in Newly Diagnosed Prostate Adenocarcinoma

    Clinical Nuclear Medicine, 2018

    DOI 10.1097/rlu.0000000000002289 PMID 30273204 46 citations (OpenAlex) Source: OpenAlex